Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc.

Investors Urged to Act as Stock Prices Plummet

Law Offices of Howard G. Smith has announced a class action lawsuit for investors who purchased shares of Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) KYTX, following the Registration Statement connected to the Company’s initial public offering (IPO) in February 2024. Investors have until February 7, 2025 to submit a lead plaintiff motion.

Investors who have incurred losses on their Kyverna investments are encouraged to reach out to the Law Offices of Howard G. Smith at 888-638-4847 or via email at howardsmith@howardsmithlaw.com to understand their legal options in this class action.

Kyverna’s IPO took place on February 8, 2024, where 14.5 million shares were sold at $22.00 each.

On June 14, 2024, Kyverna updated investors about its drug KYV-101 for lupus nephritis, revealing disappointing data about a clinical trial, which contradicted earlier claims of patient improvements.

Since the IPO, investors have faced significant financial losses. At the time of this lawsuit’s filing, Kyverna’s stock price had dropped to as low as $3.92 per share, representing a decline of over 82% from the initial offering price.

The lawsuit claims that the company’s Registration Statement and related communications during the Class Period included false or misleading statements and failed to disclose key negative information about its business and future. Key allegations include: (1) the existence of negative trial data; (2) risks surrounding the failure to disclose such trial data; and (3) that positive statements about the Company were misleading or didn’t have a proper foundation.

If you purchased Kyverna securities, possess related information, or wish to know more about your rights regarding these claims, please contact Howard G. Smith at Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by phone at (215) 638-4847 or by email at howardsmith@howardsmithlaw.com. More information can also be found on their website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in certain jurisdictions under applicable laws and ethical standards.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241213124638/en/